119 related articles for article (PubMed ID: 2434572)
21. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
Milling SW; Silvers WK; Sai T; Mintz B
Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
[TBL] [Abstract][Full Text] [Related]
22. Growth conditions of F9 embryonal carcinoma cells affect the degree of DNA methylation.
Erickson RP; Ferrucci S; Rahe B; Rosenberg MP; Morello D
Mol Biol Rep; 1984 Dec; 10(2):109-13. PubMed ID: 6098808
[TBL] [Abstract][Full Text] [Related]
23. Differences in expression of MHC products between several H-2-restricted CTL clones.
Hauptfeld V; Braciale TJ; Shreffler DC
J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
[TBL] [Abstract][Full Text] [Related]
24. Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis.
Zeff RA; Geier SS; Nathenson SG
J Immunol; 1986 Aug; 137(4):1366-70. PubMed ID: 3734458
[TBL] [Abstract][Full Text] [Related]
25. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins.
Wang M; Stepkowski SM; Hebert JS; Tian L; Yu J; Kahan BD
Ann Transplant; 1996; 1(3):26-31. PubMed ID: 9869916
[TBL] [Abstract][Full Text] [Related]
27. Different H-2 antigens expressed on two tumors derived from one BALB/c mouse.
Garrido F; Perez M; Iványi P; Schirrmacher V
Transplant Proc; 1981 Dec; 13(4):1824-7. PubMed ID: 7330970
[No Abstract] [Full Text] [Related]
28. Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes.
Hämmerling GJ; Klar D; Katzav S; Segal S; Feldman M; Wallich R; Hämmerling A
J Immunogenet; 1986; 13(2-3):153-7. PubMed ID: 3819449
[TBL] [Abstract][Full Text] [Related]
29. Analysis of T-T lymphocytes and T-accessory cell interactions using cloned T cells: MHC I restricted cloned T cells activate MHC II restricted T helper cells.
Brückner T; Di Pauli R
Cell Immunol; 1986 Apr; 99(1):182-95. PubMed ID: 2875800
[TBL] [Abstract][Full Text] [Related]
30. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.
Svane IM; Engel AM; Nielsen M; Werdelin O
Scand J Immunol; 1997 Oct; 46(4):379-87. PubMed ID: 9350289
[TBL] [Abstract][Full Text] [Related]
32. H-2 class I gene analysis in 3-methylcholanthrene-induced murine fibrosarcomas.
Castelli C; Mazzucchelli F; Sensi M; Carbone G; Parmiani G
Exp Clin Immunogenet; 1990; 7(2):129-35. PubMed ID: 2322471
[TBL] [Abstract][Full Text] [Related]
33. Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains.
Dower SK; Segal DM
J Immunol; 1985 Jan; 134(1):431-5. PubMed ID: 2578048
[TBL] [Abstract][Full Text] [Related]
34. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
Kushtai G; Barzilay J; Feldman M; Eisenbach L
Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
[TBL] [Abstract][Full Text] [Related]
35. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Manning J; Indrova M; Lubyova B; Pribylova H; Bieblova J; Hejnar J; Simova J; Jandlova T; Bubenik J; Reinis M
Immunology; 2008 Feb; 123(2):218-27. PubMed ID: 17725605
[TBL] [Abstract][Full Text] [Related]
36. Alien H-2 antigens (H-2k) appearing on a methylcholanthrene-induced tumor (H-2d): biochemical characterization.
Rogers MJ; Pierotti MA; Parmiani G; Appella E
Transplant Proc; 1980 Mar; 12(1):38-45. PubMed ID: 7368292
[No Abstract] [Full Text] [Related]
37. Molecular evidence that the H-2D and H-2L genes arose by duplication. Differences between the evolution of the class I genes in mice and humans.
Rubocki RJ; Lee DR; Lie WR; Myers NB; Hansen TH
J Exp Med; 1990 Jun; 171(6):2043-61. PubMed ID: 2351932
[TBL] [Abstract][Full Text] [Related]
38. Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.
Sharrow SO; Flaherty L; Sachs DH
J Exp Med; 1984 Jan; 159(1):21-40. PubMed ID: 6363595
[TBL] [Abstract][Full Text] [Related]
39. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells.
Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K
J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581
[TBL] [Abstract][Full Text] [Related]
40. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
Smahel M; Síma P; Ludvíková V; Marinov I; Pokorná D; Vonka V
Vaccine; 2003 Mar; 21(11-12):1125-36. PubMed ID: 12559790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
